Sign In
Buy DCPH
$25.59
+0 (+0%)
At Close: Sep 09, 2024
Dell Latitude 7220 Rugged Extreme tablet – for harsh SA environments
06:44am, Tuesday, 12'th May 2020
The tablet offers mobility and connectivity in extreme conditions.
Number of homes on Airbnb across Dublin could house all of capital's homeless
09:32pm, Sunday, 10'th May 2020
Peter McVerry Trust chief Pat Doyle described the situation in Dublin as 'madness'
Deciphera Pharmaceuticals Inc (DCPH) CEO Steve Hoerter on Q1 2020 Results - Earnings Call Transcript
08:48am, Sunday, 10'th May 2020
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Q1 2020 Earnings Conference Call May 5, 2020 16:30 ET Company Participants Jen Robinson - Vice President, Investor R
Cardtronics plc (CATM) CEO Brad Conrad on Q1 2020 Results - Earnings Call Transcript
05:22pm, Saturday, 09'th May 2020
Cardtronics plc (NASDAQ:CATM) Q1 2020 Results Conference Call May 08, 2020 08:30 AM ET Company Participants Brad Conrad - Treasurer and Head, IR Ed West - CEO G
Earnings Update: Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Just Reported And Analysts Are Trimming Their Forecasts
01:25pm, Friday, 08'th May 2020
It's shaping up to be a tough period for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), which a week ago released some...
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2020 Earnings Call Transcript
04:01pm, Wednesday, 06'th May 2020
DCPH earnings call for the period ending March 31, 2020.
Microsoft unveils Surface Book 3, ships May 21 starting at $1,599
01:00pm, Wednesday, 06'th May 2020
Microsoft today unveiled the Surface Book 3, its "most powerful laptop ever," starting at $1,599, available for preorder now, and shipping on May 21.
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
10:35pm, Tuesday, 05'th May 2020
Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of -6.25% and -97.52%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for
Deciphera Pharmaceuticals, Inc. Announces First Quarter 2020 Financial Results
08:01pm, Tuesday, 05'th May 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced financial results for the first quarter ended March 31, 2020 and provided an update on clinical and corporate developments.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
Eaton Vance Worldwide Health Sciences Fund Adds 3 Stocks to Portfolio
05:36pm, Monday, 04'th May 2020
Fund reveals 1st-quarter trades Continue reading...
Is a Surprise Coming for Deciphera (DCPH) This Earnings Season?
12:45pm, Monday, 04'th May 2020
Deciphera (DCPH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Michael Douglas Taylor Sells 25,000 Shares of Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Stock
08:44am, Saturday, 02'nd May 2020
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Director Michael Douglas Taylor sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an a
